Back to Journals » Drug Design, Development and Therapy » Volume 13

Original Research

YB-1 modulates the drug resistance of glioma cells by activation of MDM2/p53 pathway

      
Total article views   HTML views PDF downloads Totals
6,547 Dovepress* 5,954+ 1,143 7,097
PubMed Central* 593 193 786
Totals 6,547 1,336 7,883
*Since 14 January 2019

View citations on PubMed Central and Google Scholar